Presentation at the SEB Investor Conference in Copenhagen
8 January 2010, Lysaker, Norway: CEO Morten Jurs gives a presentation of Pronova BioPharma ASA at the SEB Investor Conference at 09:20 CET 8 January 2010 at Hotel Hilton Copenhagen Ariport.
The presentation is attached and is also available on http://www.pronova.com.
-- Ends --
For further information, please contact:
Hilde H. Steineger, vice president investor relations and communications:+47 48 00 42 40
Synne H. Rĝine, CFO: +47 22 53 48 92
This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)
Presentation at the SEB Investor Conference in Copenhagen Jan 2010